Rejuveron announced closing series B.
21 March 2022
21 March 2022
Total investments received (USD): 100.31m
Round value (USD): N/A
Company: Rejuveron Life Sciences
Related deals
Haya Therapeutics raised $5M with Humboldt Fund and Apollo Health Ventures
Investments
08 February 2022
Scailyte announced a first close of a series A funding round.
Investments
09 January 2022
ten23 in an equity deal to be acquired by 3i.
Secondary
25 September 2021
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain